Voyager Therapeutics (VYGR) Free Cash Flow (2017 - 2026)
Voyager Therapeutics (VYGR) free cash flow from Jun 30, 2017 to Mar 31, 2026. The TTM Voyager Therapeutics (VYGR) free cash flow is -$130M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Free Cash Flow
Quarterly Free Cash Flow
Voyager Therapeutics (VYGR) Free Cash Flow CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +13.96% |
| 5 Years TTM | +5.34% |
Annual Free Cash Flow change of Voyager Therapeutics (VYGR)
| Year | Free Cash Flow | Change |
|---|---|---|
| 2026 | -$33M | -75.25% |
| 2025 | -$135M | +617.31% |
| 2024 | -$19M | -125.22% |
| 2023 | $75M | -597.73% |
| 2022 | -$15M | -72.79% |
| 2021 | -$55M | -49.34% |
| 2020 | -$109M | -365.74% |
| 2019 | $41M | -302.72% |
| 2018 | -$20M | -69.08% |
| 2017 | -$65M | N/A |
Comparison Voyager Therapeutics (VYGR) five years free cash flow CAGR with competitors
Voyager Therapeutics (VYGR) five years free cash flow CAGR is 5.34%.